SCHEDULE: FMR LLC Boosts Beam Therapeutics Stake to 15%
Schedule 13G
FMR LLC and its affiliates, including Abigail P. Johnson, reported a 15.0% beneficial ownership stake in Beam Therapeutics Inc. common stock as of June 30, 2025.
Summary
- FMR LLC and Abigail P. Johnson reported beneficial ownership of 15,083,498.08 shares of Beam Therapeutics Inc. common stock.
- This represents 15.0% of the total outstanding common stock.
- FMR LLC holds sole voting power over 15,073,316.00 shares and sole dispositive power over 15,083,498.08 shares.
- Abigail P. Johnson, as a control person of FMR LLC, is deemed to beneficially own the same aggregate amount of shares.
- This is Amendment No. 9 to a previously filed Schedule 13G, indicating an update to an existing position.
- The securities were not acquired or held for the purpose of changing or influencing control of Beam Therapeutics Inc.
Sentiment
Score: 5
Explanation: A Schedule 13G is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance or outlook. It simply reports a significant stake.
Future Outlook
NA
Industry Context
This filing reflects a significant institutional investment in a biotechnology company, common for large asset managers like FMR LLC. It indicates a continued strategic position in the gene editing or broader biotech sector by a major investment firm.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Ownership Structure Disclosure | Disclosure of the Johnson family's predominant ownership (49% voting power) of FMR LLC's Series B voting common shares and their voting agreement, which may deem them a controlling group with respect to FMR LLC under the Investment Company Act of 1940. | NA | Clarifies the internal control structure of the reporting entity (FMR LLC) and its affiliates, which indirectly controls the reported shares. |
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional shareholder's stake, which can influence market perception and liquidity.
- Management: Awareness of a large, passive institutional holder.
Key Dates
| Date | Description |
|---|---|
| 05/23/2023 | Effective date of Power of Attorney for FMR LLC and Abigail P. Johnson |
| 08/08/2023 | Date of previous Schedule 13G filing by FMR LLC (accession number -23-002397) where Power of Attorney was incorporated by reference |
| 06/30/2025 | Date of event which requires filing of this statement (beneficial ownership as of this date) |
| 08/05/2025 | Date of filing |
Keywords
Beam Therapeutics, FMR LLC, Abigail P. Johnson, Beneficial Ownership, Schedule 13G, Institutional Investor, Biotech, Gene Editing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.